Aashka Shah
Endocrinology physician
Also affiliated: Tufts University (2023); Tufts Medical Center (2020–2023); Carle Foundation Hospital (2023); Xinjiang Medical University (2023); University of Illinois Urbana-Champaign (2023); Virginia Commonwealth University (2023–2025); Wayne State University (2012–2016); University of Arkansas Medical Center (2022); John H. Stroger, Jr. Hospital of Cook County (2023); Detroit Medical Center (2012); Tufts Children's Hospital (2020–2023); Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College (2023); Central Arkansas Veterans Healthcare System (2021–2022); Queens Hospital Center (2023); Mount Sinai Queens (2023); Pramukhswami Medical College (2023–2025); Saint Michael's Medical Center (2020); Smt. N.H.L. Municipal Medical College (2018–2023); Cook County Health and Hospitals System (2023); Bhaikaka University (2025); VCU Massey Comprehensive Cancer Center (2023); GCS Medical College (2024); Narendra Modi Medical College (2020); Karnataka Institute of Medical Sciences (2023); Icahn School of Medicine at Mount Sinai (2023)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Aashka Shah's research focuses on injury epidemiology and prevention, with a particular emphasis on venous thromboembolism in pediatric trauma patients. She has contributed to multicenter analyses investigating risk stratification and the impact of institutional prophylaxis guidelines on venous thromboembolism rates following trauma. Her work also extends to understanding risk factors and reduction strategies for Sudden Infant Death Syndrome.
Shah has also investigated rare medical cases, including isolated traumatic gallbladder injury and cysticercosis of the eyelid. Her scholarship includes work on the discontinuation of levothyroxine therapy for subclinical hypothyroidism and the prevalence of Glucose 6 Phosphate Dehydrogenase Deficiency. She has an h-index of 5 with 35 publications and 93 citations, and collaborates with researchers at the University of Arkansas for Medical Sciences, including Arwa Albashaireh and Sabah Syed.
Metrics
- h-index: 5
- Publications: 35
- Citations: 101
Positions
-
Endocrinology physician 2024–presentInstitute of Endocrinology, Diabetes, Health and hormones Endocrinology ORCID
-
Endocrinology physician publications 2021–2025University of Arkansas for Medical Sciences ORCID
Selected Publications
-
Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial (2025)
-
THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial (2023)
-
Abstract #1158365: Osteoporosis Pseudoglioma with hypergammaglobulinemia: A rare case (2022)
-
Hypothyroid Patients Describe What Brain Fog Feels Like (2022)
-
A Possible Role for Serum Thyroglobulin to Predict Structural Recurrence of Papillary Thyroid Cancer After Thyroid Lobectomy (2021)
-
A Case of Diabetic Keto Acidosis From Alpelisib (2021)
-
Glucagonoma: “A Diagnostic Challenge” (2021)
Collaboration Network
Top Collaborators
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- Hypothyroid Patients Describe What Brain Fog Feels Like
- A Possible Role for Serum Thyroglobulin to Predict Structural Recurrence of Papillary Thyroid Cancer After Thyroid Lobectomy
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- Glucagonoma: “A Diagnostic Challenge”
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- Glucagonoma: “A Diagnostic Challenge”
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- Abstract #1158365: Osteoporosis Pseudoglioma with hypergammaglobulinemia: A rare case
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- Abstract #1158365: Osteoporosis Pseudoglioma with hypergammaglobulinemia: A rare case
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Glucagonoma: “A Diagnostic Challenge”
- Glucagonoma: “A Diagnostic Challenge”
- Glucagonoma: “A Diagnostic Challenge”
Similar Researchers
Based on overlapping research topics